A detailed history of Burford Brothers, Inc. transactions in Novo Nordisk A S stock. As of the latest transaction made, Burford Brothers, Inc. holds 10,101 shares of NVO stock, worth $885,352. This represents 0.63% of its overall portfolio holdings.

Number of Shares
10,101
Previous 10,303 1.96%
Holding current value
$885,352
Previous $1.47 Billion 18.22%
% of portfolio
0.63%
Previous 0.85%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$119.07 - $145.42 $24,052 - $29,374
-202 Reduced 1.96%
10,101 $1.2 Billion
Q2 2024

Aug 14, 2024

SELL
$122.71 - $146.91 $3,558 - $4,260
-29 Reduced 0.28%
10,303 $1.47 Billion
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $23,281 - $30,989
228 Added 2.26%
10,332 $1.33 Billion
Q4 2023

Feb 16, 2024

BUY
$87.78 - $105.45 $886,929 - $1.07 Million
10,104 New
10,104 $1.05 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $198B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Burford Brothers, Inc. Portfolio

Follow Burford Brothers, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burford Brothers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Burford Brothers, Inc. with notifications on news.